Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer [Phase 1]

View source ↗

Summary

This Clinical Trial Update describes a Phase 1 study evaluating the addition of BAY 1895344 to standard chemotherapy (cisplatin or cisplatin with gemcitabine) f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Esophageal Cancer
• Gastric Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Small Cell Lung Cancer
• Triple-negative Breast Cancer
• Urothelial Carcinoma

Drugs mentioned

• BAY 1895344 (BAY 1895344)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING